• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Screening for hepatocellular carcinoma in cirrhosis.

作者信息

Bolondi Luigi

机构信息

Department of Internal Medicine and Gastroenterology, University of Bologna, Policlinico S. Orsola Malpighi, Via Albertoni 15, 40138 Bologna, Italy.

出版信息

J Hepatol. 2003 Dec;39(6):1076-84. doi: 10.1016/s0168-8278(03)00349-0.

DOI:10.1016/s0168-8278(03)00349-0
PMID:14642630
Abstract
摘要

相似文献

1
Screening for hepatocellular carcinoma in cirrhosis.肝硬化患者肝细胞癌的筛查
J Hepatol. 2003 Dec;39(6):1076-84. doi: 10.1016/s0168-8278(03)00349-0.
2
Screening for hepatocellular carcinoma.肝细胞癌筛查
J Vasc Interv Radiol. 2002 Sep;13(9 Pt 2):S185-90. doi: 10.1016/s1051-0443(07)61785-0.
3
[Mass screening for high risk group of hepatocellular carcinoma].[肝细胞癌高危人群的大规模筛查]
Nihon Rinsho. 2001 Oct;59 Suppl 6:786-90.
4
[Screening for hepatocellular carcinoma in cirrhotic patients].[肝硬化患者肝细胞癌的筛查]
Gastroenterol Clin Biol. 2000 May;24(5 Pt 2):B92-4.
5
[Incidence of hepatocellular carcinoma and consequent lessons for its management in Northeastern Hungary].[匈牙利东北部肝细胞癌的发病率及其治疗的相关经验教训]
Orv Hetil. 2016 Nov;157(45):1793-1801. doi: 10.1556/650.2016.30566.
6
Surveillance of the patients at high risk for developing hepatocellular carcinoma in Europe--between guidelines and reality.欧洲肝细胞癌高危患者的监测——介于指南与现实之间。
Ultraschall Med. 2013 Oct;34(5):483-4. doi: 10.1055/s-0033-1346750.
7
Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.美国肝硬化患者肝细胞癌筛查：一项全国性调查结果
Am J Gastroenterol. 1999 Aug;94(8):2224-9. doi: 10.1111/j.1572-0241.1999.01297.x.
8
Hepatocellular carcinoma: global epidemiology.肝细胞癌：全球流行病学
Dig Liver Dis. 2001 Mar;33(2):115-7. doi: 10.1016/s1590-8658(01)80062-1.
9
Surveillance for hepatocellular carcinoma...a hotly debated issue.肝细胞癌的监测……一个备受争议的问题。
Acta Gastroenterol Belg. 2004 Jul-Sep;67(3):255-64.
10
[Diagnosis and treatment of hepatitis C].[丙型肝炎的诊断与治疗]
MMW Fortschr Med. 2012 Nov 1;154(19):59-62. doi: 10.1007/s15006-012-1347-x.

引用本文的文献

1
All You Need to Know About TACE: A Comprehensive Review of Indications, Techniques, Efficacy, Limits, and Technical Advancement.关于经动脉化疗栓塞术你需要了解的一切：适应症、技术、疗效、局限性及技术进展的全面综述
J Clin Med. 2025 Jan 7;14(2):314. doi: 10.3390/jcm14020314.
2
Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: Consensus group recommendations from the German-speaking countries.1型酪氨酸血症患者的诊断、治疗、管理及监测：德语国家共识小组建议
J Inherit Metab Dis. 2025 Jan;48(1):e12824. doi: 10.1002/jimd.12824.
3
Redefining HCC Surveillance in India: A Call for Innovative and Inclusive Strategies.
重新定义印度的肝癌监测：呼吁创新和包容性策略。
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101474. doi: 10.1016/j.jceh.2024.101474. Epub 2024 Jun 25.
4
[Not Available].[无可用内容]
Adv Lab Med. 2023 Aug 4;4(3):227-235. doi: 10.1515/almed-2023-0054. eCollection 2023 Sep.
5
Liver FoxO1 overexpression is positively associated with the degree of liver injury in cirrhotic patients.肝硬化患者肝脏中FoxO1过表达与肝损伤程度呈正相关。
Adv Lab Med. 2023 Jul 12;4(3):218-226. doi: 10.1515/almed-2023-0014. eCollection 2023 Sep.
6
Detection of hepatocellular carcinoma during Fontan-associated liver disease follow-up: a report of three cases.法桐相关肝病随访中肝细胞癌的检测：三例报告。
Clin J Gastroenterol. 2024 Feb;17(1):148-154. doi: 10.1007/s12328-023-01892-w. Epub 2023 Nov 30.
7
Liquid biopsy for early detection of hepatocellular carcinoma.用于肝细胞癌早期检测的液体活检
Front Med (Lausanne). 2023 Sep 22;10:1218705. doi: 10.3389/fmed.2023.1218705. eCollection 2023.
8
Improving artificial intelligence pipeline for liver malignancy diagnosis using ultrasound images and video frames.利用超声图像和视频帧改进用于肝脏恶性肿瘤诊断的人工智能流水线。
Brief Bioinform. 2023 Jan 19;24(1). doi: 10.1093/bib/bbac569.
9
Construction and validation of NSMC-ASIL, a predictive model for risk assessment of malignant hepatic nodules.NSMC-ASIL的构建与验证，一种用于恶性肝结节风险评估的预测模型。
Am J Cancer Res. 2022 Nov 15;12(11):5315-5324. eCollection 2022.
10
Surgical resection versus transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma.手术切除与经动脉化疗栓塞序贯适度分割放疗治疗肝细胞癌。
Strahlenther Onkol. 2023 Mar;199(3):293-303. doi: 10.1007/s00066-022-02022-0. Epub 2022 Nov 28.